Canterbury DHB


Recombinant Factor VIII

Recombinant Factor VIII is available as Xyntha, the Pharmac-reimbursed brand.

Current usage of recombinant products for factor VIII includes:

About this Canterbury DHB document (5290):

Document Owner:

Mark Smith (see Who's Who)

Issue Date:

August 2016

Next Review:

August 2019


Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 5290